tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

AGRX Stock Latest News

Agile Therapeutics Merges with Insud Pharma Subsidiary
Company AnnouncementsAgile Therapeutics Merges with Insud Pharma Subsidiary
26d ago
8K
AGRX
Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.
PremiumPress Releases
Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.
26d ago
AGRX
Agile Therapeutics to be acquired by Insud Pharma for $1.52 per share in cash
PremiumThe Fly
Agile Therapeutics to be acquired by Insud Pharma for $1.52 per share in cash
26d ago
AGRX
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
PremiumPress Releases
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
2M ago
AGRX
Agile Therapeutics Releases Updated Investor Presentation
PremiumCompany Announcements
Agile Therapeutics Releases Updated Investor Presentation
3M ago
8K
AGRX
Agile Therapeutics’ Balancing Act: Funding Challenges Threaten R&D and Twirla Rollout
PremiumCompany AnnouncementsAgile Therapeutics’ Balancing Act: Funding Challenges Threaten R&D and Twirla Rollout
4M ago
AGRX
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
PremiumPress Releases
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
4M ago
AGRX
Agile Therapeutics reports Q4 EPS ($1.51) vs (10c) last year
PremiumThe Fly
Agile Therapeutics reports Q4 EPS ($1.51) vs (10c) last year
4M ago
AGRX
AGRX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
AGRX Upcoming Earnings Report: What to Expect?
4M ago
AGRX
Agile Therapeutics announces delisting from Nasdaq
PremiumThe Fly
Agile Therapeutics announces delisting from Nasdaq
4M ago
AGRX
Agile Therapeutics Announces Delisting from Nasdaq
PremiumPress Releases
Agile Therapeutics Announces Delisting from Nasdaq
4M ago
AGRX
Correction – Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024
PremiumPress Releases
Correction – Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024
4M ago
AGRX
Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
PremiumPress ReleasesAgile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
4M ago
AGRX
Agile Therapeutics cut to Hold at Maxim on revenue miss, likely cash needs
PremiumThe Fly
Agile Therapeutics cut to Hold at Maxim on revenue miss, likely cash needs
4M ago
AGRX
Agile Therapeutics downgraded to Hold from Buy at Maxim
PremiumThe Fly
Agile Therapeutics downgraded to Hold from Buy at Maxim
4M ago
AGRX
Agile Therapeutics completes payoff of debt
PremiumThe Fly
Agile Therapeutics completes payoff of debt
4M ago
AGRX
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
PremiumPress Releases
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
4M ago
AGRX
Agile Therapeutics Secures Funding Through Warrant Transactions
PremiumCompany Announcements
Agile Therapeutics Secures Funding Through Warrant Transactions
5M ago
8K
AGRX
Agile Therapeutics announces exercise of warrants for $4.8M gross proceeds
PremiumThe Fly
Agile Therapeutics announces exercise of warrants for $4.8M gross proceeds
5M ago
AGRX
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
PremiumPress ReleasesAgile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
5M ago
AGRX
Agile Therapeutics Gains Extension on Loan and Nasdaq Compliance
PremiumCompany Announcements
Agile Therapeutics Gains Extension on Loan and Nasdaq Compliance
5M ago
8K
AGRX
Agile Therapeutics granted extension by Nasdaq to regain compliance
PremiumThe Fly
Agile Therapeutics granted extension by Nasdaq to regain compliance
5M ago
AGRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >